PROVECTUS BIOPHARMACEUTICALS, INC. Loss Contingency, Receivable, Current
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) had Loss Contingency, Receivable, Current of $1.35 thousand as of 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency › Loss Contingency, Related Receivable › Loss Contingency, Receivable
us-gaap:LossContingencyReceivableCurrent · last filed 2021-11-10
- 2021-09-30: Loss Contingency, Receivable, Current $1.35K.
- 2021-06-30: Loss Contingency, Receivable, Current $5.41K.
- 2021-03-31: Loss Contingency, Receivable, Current $4.39K.
- 2020-12-31: Loss Contingency, Receivable, Current $3.93K.
| Period end | Loss Contingency, Receivable, Current |
|---|---|
| 2021-09-30 | $1.35K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $5.41K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $4.39K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $3.93K 10-Q · filed 2021-11-10 |
| 2020-09-30 | $5.93K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $3.78K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $74.23K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $55.06K 10-K · filed 2021-03-02 |
| 2019-09-30 | $290.08K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $292.71K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $604.27K 10-Q · filed 2019-05-13 |
| 2018-12-31 | $595.33K 10-K · filed 2020-03-05 |
| 2018-09-30 | $2.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $974.77K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $200.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $452.38K 10-K · filed 2019-03-07 |
| 2017-06-30 | $100.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $200.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $300.00K 10-K · filed 2018-03-23 |
| 2016-09-30 | $50.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $200.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $350.00K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $500.00K 10-K · filed 2017-03-31 |
| 2015-06-30 | $200.00K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $466.67K 10-Q · filed 2015-05-07 |
| 2014-12-31 | $733.33K 10-K · filed 2016-03-30 |